Silibinin oral disintegration tablet and its preparing method
Patent Information
- Authority / Receiving Office
- CN Ā· China
- Current Assignee / Owner
- COSCI MED TECH CO LTD
- Publication Date
- 2005-03-02
- Estimated Expiration
- Not applicable Ā· inactive patent
Abstract
Description
[technical field]
[0001] The present invention relates to a silibinin preparation which has the obvious effect of protecting and stabilizing liver cells and is used for treating acute and chronic hepatitis, liver cirrhosis, liver poisoning and other diseases, especially relates to a silybin preparation with quick release effect Orally disintegrating tablet formulation. [Background technique]
[0002] Silybin is a monomeric compound extracted from silymarin, which has the same indications and clinical efficacy as silymarin.
[0003] Silibinin has low bioavailability due to its poor solubility. At present, the dosage forms of silibinin preparations mainly include common tablet and capsule dosage forms. Orally disintegrating tablet preparations or related literature of silybin have not been found. The silibinin is made into an orally disintegrating tablet, which is convenient for patients to carry and take, and is conducive to improving the patient's compliance, thereby ensu...